§FMCSR.com
Historical textIn force on June 15, 2018Source: eCFR

§ 40.29 Where is other information on employer responsibilities found in this regulation?

Wording effective January 1, 2018, superseded May 2, 2023.

eCFR as of June 15, 2018 ↗

You can find other information on the responsibilities of employers in the following sections of this part:

§ 40.3—Definition.

§ 40.35—Information about DERs that employers must provide collectors.

§ 40.45—Modifying CCFs, Use of foreign-language CCFs.

§ 40.47—Use of non-Federal forms for DOT tests or Federal CCFs for non-DOT tests.

§ 40.67—Requirements for direct observation.

§ 40.173—Responsibility to ensure test of split specimen.

§ 40.193—Action in “shy bladder” situations.

§ 40.197—Actions following report of a dilute specimen.

§ 40.207—Actions following a report of a cancelled drug test.

§ 40.209—Actions following and consequences of non-fatal flaws in drug tests.

§ 40.215—Information about DERs that employers must provide BATs and STTs.

§ 40.225—Modifying ATFs; use of foreign-language ATFs.

§ 40.227—Use of non-DOT forms for DOT tests or DOT ATFs for non-DOT tests.

§ 40.235 (c) and (d)—responsibility to follow instructions for ASDs.

§ 40.255 (b)—receipt and storage of alcohol test information.

§ 40.265 (c)-(e)—actions in “shy lung” situations.

§ 40.267—Cancellation of alcohol tests.

§ 40.271—Actions in “correctable flaw” situations in alcohol tests.

§ 40.273—Actions following cancelled tests in alcohol tests.

§ 40.275—Actions in “non-fatal flaw” situations in alcohol tests.

§§ 40.287-40.289—Responsibilities concerning SAP services.

§§ 40.295-40.297—Prohibition on seeking second SAP evaluation or changing SAP recommendation.

§ 40.303—Responsibilities concerning aftercare recommendations.

§ 40.305—Responsibilities concerning return-to-duty decision.

§ 40.309—Responsibilities concerning follow-up tests.

§ 40.321—General confidentiality requirement.

§ 40.323—Release of confidential information in litigation.

§ 40.331—Other circumstances for the release of confidential information.

§ 40.333—Record retention requirements.

§ 40.345—Choice of who reports drug testing information to employers.

[65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001, as amended at 82 FR 52244, Nov. 13, 2017]

Amendment history

7 distinct wordings on file since Oct. 1, 1996
  1. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001, as amended at 82 FR 52244, Nov. 13, 2017]
  2. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001, as amended at 82 FR 52244, Nov. 13, 2017]
  3. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001]
  4. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001]
  5. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001.]
  6. [54 FR 49866, Dec. 1, 1989, as amended at 59 FR 7356, Feb. 15, 1994; 59 FR 43001, Aug. 19, 1994; 63 FR 65129, Nov. 25, 1998]
  7. Oct. 1, 1996 → Oct. 1, 1999annual editions 1996–1998
    [54 FR 49866, Dec. 1, 1989, as amended at 59 FR 7356, Feb. 15, 1994; 59 FR 43001, Aug. 19, 1994]

A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.